Do No Harm: Mitigating Human Rights Risks when Interacting with International Medical Institutions & Professionals in Transplantation Medicine
(Scroll down for introduction video)
Organ trafficking, forced organ harvesting and unethical organ transplantation is a global issue. International law firm, Global Rights Compliance (GRC), has published a ‘world’s first’ Legal Advisory Report and Policy Guidance, Do No Harm: Mitigating Human Rights Risks when Interacting with International Medical Institutions & Professionals in Transplantation Medicine.
The Legal Advisory Report and Policy Guidance explores the risks of international collaborations in transplant medicine, research and training and the hard and soft law obligations that govern those partnerships. It also highlights high risk countries such as China, and provides practical advice for mitigating risks and outlines circumstances where disengagement may be required.
This Advisory includes information relevant to a range of stakeholders including hospitals, universities, professional societies, medical journals, independent professional bodies, medical schools and associated medical professionals in the field of organ transplantation. It will also be of interest to lawyers, ethicists, think tanks and policy makers.
WATCH THE LAUNCH EVENTS SUPPORTED BY THE BRITISH MEDICAL ASSOCIATION & DOWNLOAD THE DOCUMENTS ON THE GRC WEBSITE HERE
GRC Legal Advisory Report & Policy Guidance
Do No Harm: Mitigating Human Rights Risks when Interacting with International Medical Institutions & Professionals in Transplantation Medicine
(Scroll down for introduction video)
Organ trafficking, forced organ harvesting and unethical organ transplantation is a global issue. International law firm, Global Rights Compliance (GRC), has published a ‘world’s first’ Legal Advisory Report and Policy Guidance, Do No Harm: Mitigating Human Rights Risks when Interacting with International Medical Institutions & Professionals in Transplantation Medicine.
The Legal Advisory Report and Policy Guidance explores the risks of international collaborations in transplant medicine, research and training and the hard and soft law obligations that govern those partnerships. It also highlights high risk countries such as China, and provides practical advice for mitigating risks and outlines circumstances where disengagement may be required.
This Advisory includes information relevant to a range of stakeholders including hospitals, universities, professional societies, medical journals, independent professional bodies, medical schools and associated medical professionals in the field of organ transplantation. It will also be of interest to lawyers, ethicists, think tanks and policy makers.
WATCH THE LAUNCH EVENTS SUPPORTED BY THE BRITISH MEDICAL ASSOCIATION & DOWNLOAD THE DOCUMENTS ON THE GRC WEBSITE HERE
https://endtransplantabuse.org/grc-donoharm/